APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 42 filers reported holding APREA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $44,000 | – | 15,173 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 1,377,654 | $6,778,000 | 2.28% |
| Versant Venture Management, LLC | 1,426,328 | $7,018,000 | 0.73% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $206,000 | 0.38% |
| Redmile Group, LLC | 1,268,718 | $6,242,000 | 0.08% |
| Gyon Technologies Capital Management, LP | 41,801 | $206,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 163,681 | $805,000 | 0.06% |
| Palo Alto Investors LP | 128,770 | $634,000 | 0.03% |
| Walleye Capital LLC | 100,800 | $496,000 | 0.03% |
| Virtus ETF Advisers LLC | 10,261 | $50,000 | 0.02% |
| Candriam S.C.A. | 362,346 | $1,783,000 | 0.01% |